Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy
07 nov. 2022 16h05 HE
|
Akoya Biosciences, Inc.
Each panel focuses on distinct areas of tumor biology and response to therapy which are of greatest interest to translational and clinical researchers Simplifies biomarker assay development and...
Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic
28 juin 2022 08h05 HE
|
Akoya Biosciences, Inc.
The OncoSignature® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to respond to ACR-368, an advanced Phase 2 targeted...
Akoya Biosciences Announces Ehab A. El-Gabry, MD, as Chief Medical Officer
19 avr. 2022 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced the appointment of Dr. Ehab A. El-Gabry as the company’s...
Akoya Biosciences to Showcase New Data on PhenoCycler-Fusion at the AACR Annual Meeting 2022
06 avr. 2022 08h05 HE
|
Akoya Biosciences, Inc.
Company to present industry’s first 100-plex, whole slide dataset for deep spatial phenotyping of the tumor microenvironmentThe Company will also showcase its novel protein chemistry to accelerate...
Akoya Biosciences Appoints Marilee Moy as Chief People Officer
20 janv. 2022 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Marilee Moy as Chief People...
Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
05 janv. 2022 07h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass. and MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, and Bio-Techne (NASDAQ: TECH), a global life sciences...
Akoya Biosciences Unveils Comprehensive Roadmap of Innovations at Inaugural Spatial Day Event
15 déc. 2021 12h00 HE
|
Akoya Biosciences, Inc.
-Company previews an integrated suite of solutions, including the new PhenoCycler™-Fusion System for unbiased spatial discovery, at unprecedented speeds -Innovations include a novel spatial...
Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers
13 déc. 2021 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, and PathAI, a global leader in artificial intelligence (AI)-powered...
Akoya Biosciences to Host Inaugural Spatial Day on December 15, 2021
22 nov. 2021 08h05 HE
|
Akoya Biosciences, Inc.
The program will highlight the latest breakthroughs and applications in spatial biology and the company’s latest innovations to accelerate breakthroughs in discovery and clinical research. ...
Akoya Biosciences to Present Data at SITC 2021 Highlighting Novel Spatial Biology Applications
04 nov. 2021 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced that new data generated with its CODEX® and Phenoptics™...